Literature DB >> 15501934

The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells.

Thuy Thanh Tran1, Aditya Mittal, Tanya Aldinger, Joseph W Polli, Andrew Ayrton, Harma Ellens, Joe Bentz.   

Abstract

The human multi-drug resistance membrane transporter, P-glycoprotein, or P-gp, has been extensively studied due to its importance to human health and disease. Thus far, the kinetic analysis of P-gp transport has been limited to steady-state Michaelis-Menten approaches or to compartmental models, neither of which can prove molecular mechanisms. Determination of the elementary kinetic rate constants of transport will be essential to understanding how P-gp works. The experimental system we use is a confluent monolayer of MDCKII-hMDR1 cells that overexpress P-gp. It is a physiologically relevant model system, and transport is measured without biochemical manipulations of P-gp. The Michaelis-Menten mass action reaction is used to model P-gp transport. Without imposing the steady-state assumptions, this reaction depends upon several parameters that must be simultaneously fitted. An exhaustive fitting of transport data to find all possible parameter vectors that best fit the data was accomplished with a reasonable computation time using a hierarchical algorithm. For three P-gp substrates (amprenavir, loperamide, and quinidine), we have successfully fitted the elementary rate constants, i.e., drug association to P-gp from the apical membrane inner monolayer, drug dissociation back into the apical membrane inner monolayer, and drug efflux from P-gp into the apical chamber, as well as the density of efflux active P-gp. All three drugs had overlapping ranges for the efflux active P-gp, which was a benchmark for the validity of the fitting process. One novel finding was that the association to P-gp appears to be rate-limited solely by drug lateral diffusion within the inner monolayer of the plasma membrane for all three drugs. This would be expected if P-gp structure were open to the lipids of the apical membrane inner monolayer, as has been suggested by recent structural studies. The fitted kinetic parameters show how P-gp efflux of a wide range of xenobiotics has been maximized.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501934      PMCID: PMC1305048          DOI: 10.1529/biophysj.104.045633

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  65 in total

Review 1.  Protein folding in the landscape perspective: chevron plots and non-Arrhenius kinetics.

Authors:  H S Chan; K A Dill
Journal:  Proteins       Date:  1998-01

2.  Measuring pKa of activation and pKi of inactivation for influenza hemagglutinin from kinetics of membrane fusion of virions and of HA expressing cells.

Authors:  Aditya Mittal; Tong Shangguan; Joe Bentz
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

3.  Endogenous drug transporters in in vitro and in vivo models for the prediction of drug disposition in man.

Authors:  Lay Beng Goh; Kevin J Spears; Denggao Yao; Andy Ayrton; Paul Morgan; C Roland Wolf; Thomas Friedberg
Journal:  Biochem Pharmacol       Date:  2002-12-01       Impact factor: 5.858

4.  A novel electron paramagnetic resonance approach to determine the mechanism of drug transport by P-glycoprotein.

Authors:  Hiroshi Omote; Marwan K Al-Shawi
Journal:  J Biol Chem       Date:  2002-09-19       Impact factor: 5.157

Review 5.  Multidrug transporters and antibiotic resistance in Lactococcus lactis.

Authors:  Gerrit J Poelarends; Piotr Mazurkiewicz; Wil N Konings
Journal:  Biochim Biophys Acta       Date:  2002-09-10

6.  Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?

Authors:  Fuxing Tang; Kazutoshi Horie; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

7.  Are MDCK cells transfected with the human MRP2 gene a good model of the human intestinal mucosa?

Authors:  Fuxing Tang; Kazutoshi Horie; Ronald T Borchardt
Journal:  Pharm Res       Date:  2002-06       Impact factor: 4.200

8.  Transition state P-glycoprotein binds drugs and modulators with unchanged affinity, suggesting a concerted transport mechanism.

Authors:  Qin Qu; Joseph W K Chu; Frances J Sharom
Journal:  Biochemistry       Date:  2003-02-11       Impact factor: 3.162

9.  Binding of a fluorescent lipid amphiphile to albumin and its transfer to lipid bilayer membranes.

Authors:  Magda S C Abreu; Luís M B B Estronca; Maria João Moreno; Winchil L C Vaz
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

Review 10.  Structure and mechanism of ABC transporters.

Authors:  Lutz Schmitt; Robert Tampé
Journal:  Curr Opin Struct Biol       Date:  2002-12       Impact factor: 6.809

View more
  19 in total

1.  The importance of villous physiology and morphology in mechanistic physiologically-based pharmacokinetic models.

Authors:  Emile P Chen; Guoying Tai; Harma Ellens
Journal:  Pharm Res       Date:  2013-08-30       Impact factor: 4.200

2.  Kinetic considerations for the quantitative assessment of efflux activity and inhibition: implications for understanding and predicting the effects of efflux inhibition.

Authors:  J Cory Kalvass; Gary M Pollack
Journal:  Pharm Res       Date:  2006-12-27       Impact factor: 4.200

3.  Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells.

Authors:  Yun-Xia Li; Liang-Hong Ye; Xue-Hua Jiang; Cheng Peng
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-02-20       Impact factor: 2.441

4.  The steady-state Michaelis-Menten analysis of P-glycoprotein mediated transport through a confluent cell monolayer cannot predict the correct Michaelis constant Km.

Authors:  Joe Bentz; Thuy Thanh Tran; Joseph W Polli; Andrew Ayrton; Harma Ellens
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

5.  Cells on pores: a simulation-driven analysis of transcellular small molecule transport.

Authors:  Xinyuan Zhang; Nan Zheng; Peng Zou; Huaning Zhu; Juan P Hinestroza; Gus R Rosania
Journal:  Mol Pharm       Date:  2010-04-05       Impact factor: 4.939

Review 6.  Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.

Authors:  Noora Sjöstedt; Hanna Kortejärvi; Heidi Kidron; Kati-Sisko Vellonen; Arto Urtti; Marjo Yliperttula
Journal:  Pharm Res       Date:  2014-01       Impact factor: 4.200

7.  Topical Treatment for Cutaneous Leishmaniasis: Dermato-Pharmacokinetic Lead Optimization of Benzoxaboroles.

Authors:  Katrien Van Bocxlaer; Eric Gaukel; Deirdre Hauser; Seong Hee Park; Sara Schock; Vanessa Yardley; Ryan Randolph; Jacob J Plattner; Tejal Merchant; Simon L Croft; Robert T Jacobs; Stephen A Wring
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

8.  In vitro P-glycoprotein activity does not completely explain in vivo efficacy of novel centrally effective oxime acetylcholinesterase reactivators.

Authors:  Mary Beth Dail; Edward Caldwell Meek; Howard Wayne Chambers; Janice Elaine Chambers
Journal:  Drug Chem Toxicol       Date:  2018-05-03       Impact factor: 3.356

Review 9.  Computational approaches to analyse and predict small molecule transport and distribution at cellular and subcellular levels.

Authors:  Kyoung Ah Min; Xinyuan Zhang; Jing-yu Yu; Gus R Rosania
Journal:  Biopharm Drug Dispos       Date:  2013-12-10       Impact factor: 1.627

10.  Cost, effectiveness and environmental relevance of multidrug transporters in sea urchin embryos.

Authors:  Bryan J Cole; Amro Hamdoun; David Epel
Journal:  J Exp Biol       Date:  2013-08-02       Impact factor: 3.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.